Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
6 NC counties are under alert, including Johnston County.
Program
Thursday at 6 on WRAL: School bus safety: After years of mechanical issues, including fires â whatâs being done this year to prevent a disaster?
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Aligos Therapeutics Inc
(NQ:
ALGS
)
13.75
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aligos Therapeutics Inc
< Previous
1
2
3
4
5
6
Next >
Aligos Therapeutics Presents Positive Clinical Data at Hep-DART 2023 from Phase 1 Studies in HBV (ALG-000184) and NASH (ALG-055009)
December 07, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Aligos Therapeutics To Present at the Piper Sandler Healthcare Conference
November 20, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Why Is Tharimmune (THAR) Stock Down 8% Today?
November 20, 2023
Tharimmune stock is falling after the company announced a reverse stock split for THAR shares that goes into effect later today.
Via
InvestorPlace
Earnings Outlook For Aligos Therapeutics
November 01, 2023
Via
Benzinga
Why Is Aligos Therapeutics (ALGS) Stock Down 5% Today?
November 20, 2023
Aligos Therapeutics stock is falling alongside news of a secondary offering for ALGS that it won't see any proceeds of the sales from.
Via
InvestorPlace
Why Applied UV Shares Are Trading Higher By Around 96%; Here Are 20 Stocks Moving Premarket
November 20, 2023
Shares of Applied UV, Inc. (NASDAQ: AUVI) shares jumped in pre-market trading after the company reported third-quarter results.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 20, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
November 20, 2023
It's time to start the week with a breakdown of the biggest pre-market stock movers traders need to watch on Monday morning!
Via
InvestorPlace
Aligos Therapeutics Presents Clinical and Nonclinical Data at the AASLD Liver Meeting® 2023 Demonstrating that ALG-055009 has a Favorable Risk-Benefit Profile
November 13, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Aligos Therapeutics Presents Positive Data at the AASLD Liver Meeting® 2023 Demonstrating that Treatment with ALG-000184 (CAM-E) Results in Significant Multi-log Reductions in Hepatitis B Antigens (HBsAg, HBcrAg and HBeAg)
November 10, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Aligos Therapeutics to Present Multiple Posters at AASLD’s The Liver Meeting® 2023, Highlighting Progress for Its Clinical Stage Portfolio, including Lead THR-β Agonist for the Treatment of NASH, ALG-055009; ALG-000184, the Company’s Lead CAM-E Molecule,
November 07, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Aligos Therapeutics to Host KOL Event to Discuss ALG-000184 Phase 1, AASLD Late Breaker Data
November 03, 2023
November 16 Event to feature KOL perspective on Emerging HBV Therapies
From
Aligos Therapeutics
Via
GlobeNewswire
Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2023 Financial Results
November 02, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
October 27, 2023
Via
Benzinga
Aligos Therapeutics to Announce 3rd Quarter Results on November 2, 2023
October 26, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Aligos Therapeutics To Present Late Breaking Poster on ALG-000184, its CAM-E Drug Candidate, at The Liver Meeting® 2023
October 25, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Why Aligos Therapeutics (ALGS) Stock Is Nosediving
October 23, 2023
Aligos Therapeutics Inc (NASDAQ: ALGS) shares are trading lower by 15.8% to $0.64 Monday afternoon after the company announced $92 million in private placement financing
Via
Benzinga
Aligos Therapeutics Announces $92 Million Private Placement Financing
October 23, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Aligos Therapeutics Announces Award of an $8.5 Million NIAID Contract to Advance Development of Best-In-Class Pan-Coronavirus Protease Inhibitor, ALG-097558
October 03, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Aligos Therapeutics Announces IND Clearance for NASH lead, ALG-055009
September 21, 2023
- Phase 2a NASH protocol on track to be submitted to the IND in Q4 2023, enrollment expected to begin in Q1 2024
From
Aligos Therapeutics
Via
GlobeNewswire
Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2023 Financial Results
August 03, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Aligos Therapeutics to Announce Second Quarter Results on August 03, 2023
July 27, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Aligos Therapeutics Announces the Selection of Stephen Harrison, MD as Principal Investigator of Ph2a Study and Key Study Design Elements/Milestones for NASH Drug Candidate, ALG-055009
July 19, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Aligos Therapeutics Presents Data from its Liver Disease Programs at the European Association for the Study of the Liver (EASL) Congress 2023
June 21, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Aligos Therapeutics to Present Data on its Liver Disease Programs at the European Association for the Study of the Liver (EASL) Congress 2023
June 07, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Aligos Therapeutics to Present at the Jefferies 2023 Healthcare Conference
May 24, 2023
From
Aligos Therapeutics
Via
GlobeNewswire
Week In Review: LaNova Sells Pre-Clinical ADC To AstraZeneca In $600 Million Deal
May 20, 2023
LaNova Medicines has sold global rights for a pre-clinical antibody drug conjugate candidate to AstraZeneca for $600 million, including $55 million upfront plus royalties on sales. Meanwhile, Amoytop...
Via
Talk Markets
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 15, 2023
Via
Benzinga
Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
May 15, 2023
Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash.
Via
Benzinga
Why NeoGames Shares Are Trading Higher By 121%; Here Are 20 Stocks Moving Premarket
May 15, 2023
Gainers NeoGames S.A. (NASDAQ: NGMS) shares surged 121% to $28.38 in pre-market trading as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.